collection
MENU ▼
Read by QxMD icon Read
search

rosacea

shared collection
33 papers 0 to 25 followers
https://www.readbyqxmd.com/read/29214107/diet-and-rosacea-the-role-of-dietary-change-in-the-management-of-rosacea
#1
REVIEW
Emma Weiss, Rajani Katta
Dietary change may play a role in the therapy of rosacea. Certain foods and beverages may act as "triggers" for rosacea exacerbations. These may be divided into heat-related, alcohol-related, capsaicin-related, and cinnamaldehyde-related. One potential pathogenic mechanism may be via the activation of transient receptor potential cation channels, which result in neurogenic vasodilatation. Further research is needed on the role of the gut skin connection in rosacea. Epidemiologic studies suggest that patients with rosacea have a higher prevalence of gastrointestinal disease, and one study reported improvement in rosacea following successful treatment of small intestinal bacterial overgrowth...
October 2017: Dermatology Practical & Conceptual
https://www.readbyqxmd.com/read/29364439/thickness-of-carotid-intima-and-epicardial-fat-in-rosacea-a-cross-sectional-study
#2
Asli Akin Belli, Ilknur Altun, Ibrahim Altun
BACKGROUND: Rosacea is a chronic facial skin disease associated with excessive inflammatory response to various triggers. Although some studies have supported the increased risk of cardiovascular diseases in rosacea, it has not been completely accepted. OBJECTIVE: We aimed to investigate epicardial fat thickness and carotid intima-media thickness as cardiovascular risk predictors in rosacea patients. METHODS: We conducted a cross-sectional study including 40 rosacea patients and 40 controls...
November 2017: Anais Brasileiros de Dermatologia
https://www.readbyqxmd.com/read/29409914/efficacy-and-safety-of-oxymetazoline-cream-1-0-for-treatment-of-persistent-facial-erythema-associated-with-rosacea-findings-from-the-52-week-open-label-reveal-trial
#3
Zoe Diana Draelos, Michael H Gold, Robert A Weiss, Leslie Baumann, Steven K Grekin, Deanne Mraz Robinson, Steven E Kempers, Nancy Alvandi, Emily Weng, David R Berk, Gurpreet Ahluwalia
BACKGROUND: Limited treatments are available for persistent erythema of rosacea. OBJECTIVE: To examine long-term safety and efficacy of oxymetazoline cream 1.0% in rosacea patients with moderate to severe persistent erythema. METHODS: Patients applied oxymetazoline once daily for 52 weeks. Safety assessments included treatment-emergent adverse events (TEAEs), skin blanching, inflammatory lesion counts, telangiectasia, disease severity, and rebound effect...
January 30, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/29409915/efficacy-and-safety-of-topical-oxymetazoline-cream-1-0-for-treatment-of-persistent-facial-erythema-associated-with-rosacea-findings-from-the-two-phase-3-29-day-randomized-controlled-reveal-trials
#4
Linda Stein-Gold, Leon H Kircik, Zoe Diane Draelos, Philip Werschler, Janet DuBois, Edward Lain, Leslie Baumann, David J Goldberg, Joely Kaufman, Emil A Tanghetti, Nancy Alvandi, Emily Weng, David R Berk, Gurpreet Ahluwalia
BACKGROUND: Rosacea is a chronic dermatologic condition with limited treatment options. OBJECTIVE: To evaluate topical oxymetazoline cream 1.0% in patients with moderate to severe persistent erythema of rosacea. METHODS: Data were pooled from two identically designed phase 3 trials. Patients were randomized to receive oxymetazoline or vehicle once daily for 29 days and were followed for 28 days posttreatment. The primary efficacy outcome was the proportion of patients with ≥2-grade improvement from baseline on both Clinician Erythema Assessment (CEA) and Subject Self-Assessment (SSA) at 3, 6, 9, and 12 hours postdose, day 29...
January 30, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/25548852/impact-of-intradermal-abobotulinumtoxina-on-facial-erythema-of-rosacea
#5
Bradley S Bloom, Lea Payongayong, Andrea Mourin, David J Goldberg
BACKGROUND: Facial erythema is a frequent and often distressing complaint of patients with rosacea. Treatment of facial erythema with botulinum toxin has previously been proposed and reported. However, the current literature has mixed results. OBJECTIVE: The primary objective of this study was to evaluate the safety and efficacy of intradermal abobotulinumtoxinA on facial erythema of rosacea. MATERIALS AND METHODS: Twenty-five subjects aged 35 to 70 years with Fitzpatrick skin Types I to IV and facial erythema of erythematotelangiectatic rosacea were enrolled in the trial...
January 2015: Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery [et Al.]
https://www.readbyqxmd.com/read/25765295/botulinum-toxin-for-the-treatment-of-refractory-erythema-and-flushing-of-rosacea
#6
Kui Young Park, Moo Yeol Hyun, Se Yeong Jeong, Beom Joon Kim, Myeung Nam Kim, Chang Kwun Hong
BACKGROUND: Persistent erythema and severe rosacea flushing can cause significant physical discomfort and emotional stress to patients. Currently, no satisfactory treatments are available. METHODS: We report two cases of refractory flushing and erythema of rosacea that were successfully treated with intradermal botulinum toxin injections. RESULTS: Good cosmetic results were achieved for both patients. The side effects during and after treatment were mild pain and localized bruising; these symptoms resolved within several days without further treatment...
2015: Dermatology: International Journal for Clinical and Investigative Dermatology
https://www.readbyqxmd.com/read/25897253/update-on-the-management-of-rosacea
#7
Allison P Weinkle, Vladyslava Doktor, Jason Emer
Refining diagnostic criteria has identified key characteristics differentiating rosacea, a chronic skin disorder, from other common cutaneous inflammatory conditions. The current classification system developed by the National Rosacea Society Expert Committee consists of erythematotelangiectatic, papulopustular, phymatous, and ocular subtypes. Each subtype stands as a unique entity among a spectrum, with characteristic symptoms and physical findings, along with an intricate pathophysiology. The main treatment modalities for rosacea include topical, systemic, laser, and light therapies...
2015: Clinical, Cosmetic and Investigational Dermatology
https://www.readbyqxmd.com/read/27843919/rosacea-management
#8
REVIEW
Manal Abokwidir, Steven R Feldman
BACKGROUND: Rosacea is a chronic inflammatory skin condition associated with four distinct subtypes: erythematotelangiectatic, papulopustular, phymatous, and ocular. PURPOSE: To review the different kinds of management for all subtypes. METHODS: We divided rosacea management into three main categories: patient education, skin care, and pharmacological/procedural interventions. RESULTS: Flushing is better prevented rather than treated, by avoiding specific triggers, decreasing transepidermal water loss by moisturizers, and blocking ultraviolet light...
September 2016: Skin Appendage Disorders
https://www.readbyqxmd.com/read/28300926/rosacea-fulminans-unusual-clinical-presentation-of-rosacea
#9
Jessica Castiel Coutinho, Danielle Cristine Westphal, Laís Cruz Lobato, Antônio Pedro Mendes Schettini, Mônica Santos
Rosacea fulminans or pyoderma faciale is a rare cutaneous disorder that usually affects women usually between the ages of 15-46. The disease is characterized by sudden onset of papules, pustules, cysts, and painful coalescing nodules with red-cyanotic centrofacial erythema. Although its etiology remains unknown, hormonal, immunological, and vascular factors have been reported. Early diagnosis and prompt treatment should minimize unsightly scars. We report a case of a 33-year-old female patient treated with traditional doses of doxycycline, with improvement of the lesions and regression of the condition in two months...
September 2016: Anais Brasileiros de Dermatologia
https://www.readbyqxmd.com/read/28191680/friends-or-foes-host-defense-antimicrobial-peptides-and-proteins-in-human-skin-diseases
#10
REVIEW
François Niyonsaba, Chanisa Kiatsurayanon, Panjit Chieosilapatham, Hideoki Ogawa
Host defense peptides/proteins (HDPs), also known as antimicrobial peptides/proteins (AMPs), are key molecules in the cutaneous innate immune system. AMPs/HDPs historically exhibit broad-spectrum killing activity against bacteria, enveloped viruses, fungi and several parasites. Recently, AMPs/HDPs were shown to have important biological functions, including inducing cell proliferation, migration and differentiation; regulating inflammatory responses; controlling the production of various cytokines/chemokines; promoting wound healing; and improving skin barrier function...
November 2017: Experimental Dermatology
https://www.readbyqxmd.com/read/28243492/usefulness-of-dermoscopy-in-the-diagnosis-and-monitoring-treatment-of-demodicidosis
#11
Paula Friedman, Emilia Cohen Sabban, Horacio Cabo
Demodicidosis is a common infestation and should be considered in the differential diagnosis of recurrent or recalcitrant perioral dermatitis or rosacea-like eruptions of the face. We report on a 34-year-old male, who presented with facial erythema and desquamation accompanied by a pruritic sensation. Dermoscopic examination revealed Demodex tails and Demodex follicular openings, both specific features of this entity. Microscopically, standardized skin surface biopsy test was pathogenic and the patient had positive response to anti-demodectic drugs...
January 2017: Dermatology Practical & Conceptual
https://www.readbyqxmd.com/read/28243927/topical-treatment-of-rosacea-with-ivermectin-inhibits-gene-expression-of-cathelicidin-innate-immune-mediators-ll-37-and-klk5-in-reconstructed-and-ex-vivo-skin-models
#12
Séverine Thibaut de Ménonville, Carine Rosignoli, Estelle Soares, Manon Roquet, Béatrice Bertino, Jean-Paul Chappuis, Claire Defoin-Platel/Chaussade, David Piwnica
INTRODUCTION: Numerous intrinsic and extrinsic factors have been associated with the pathophysiology of rosacea, including dysregulation of innate immunity. A high level of cathelicidin antimicrobial peptides (e.g., LL-37) has been shown in the facial skin of patients with rosacea. Excessive production of both LL-37 and KLK5, the serine protease responsible for its cleavage, has been suggested to play a role in the pathophysiology of rosacea. Ivermectin 10 mg/g cream, indicated for the treatment of inflammatory lesions of rosacea, is reported to have dual anti-parasitic and anti-inflammatory properties...
June 2017: Dermatology and Therapy
https://www.readbyqxmd.com/read/27051311/new-developments-in-the-treatment-of-rosacea-role-of-once-daily-ivermectin-cream
#13
REVIEW
Leah A Cardwell, Hossein Alinia, Sara Moradi Tuchayi, Steven R Feldman
Rosacea is a chronic dermatological disorder with a variety of clinical manifestations localized largely to the central face. The unclear etiology of rosacea fosters therapeutic difficulty; however, subtle clinical improvement with pharmacologic treatments of various drug categories suggests a multifactorial etiology of the disease. Factors that may contribute to disease pathogenesis include immune abnormality, vascular abnormality, neurogenic dysregulation, presence of cutaneous microorganisms, UV damage, and skin barrier dysfunction...
2016: Clinical, Cosmetic and Investigational Dermatology
https://www.readbyqxmd.com/read/27376863/integrative-concepts-of-rosacea-pathophysiology-clinical-presentation-and-new-therapeutics
#14
REVIEW
Anna D Holmes, Martin Steinhoff
Rosacea is a chronic relapsing inflammatory skin disease with high prevalence worldwide. Recent research suggests that dysregulation of innate and adaptive immune pathways as well as neurovascular changes is present, with different degrees of importance in the various subtypes. Neither the aetiology, genetics nor pathophysiological basis of the vascular, inflammatory or fibrotic changes is well understood. The clinical spectrum comprises a huge variability from erythema (vasodilation) to papules/pustules (inflammatory infiltrate) to phymata (fibrosis, glandular hyperplasia) making it a valuable human disease model to understand the interplay between the neurovascular and immune systems as well as the progression from chronic inflammation to fibrosis in skin...
August 2017: Experimental Dermatology
https://www.readbyqxmd.com/read/26830864/clustering-of-autoimmune-diseases-in-patients-with-rosacea
#15
COMPARATIVE STUDY
Alexander Egeberg, Peter Riis Hansen, Gunnar Hilmar Gislason, Jacob Pontoppidan Thyssen
BACKGROUND: Rosacea is a common inflammatory skin condition that shares genetic risk loci with autoimmune diseases such as type 1 diabetes mellitus (T1DM) and celiac disease. A recent genomewide association study identified 90 genetic regions associated with T1DM, celiac disease, multiple sclerosis, and/or rheumatoid arthritis, respectively. However, a possible association with rosacea was not investigated. OBJECTIVE: We evaluated the association between rosacea and T1DM, celiac disease, multiple sclerosis, and rheumatoid arthritis, respectively...
April 2016: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/25381388/the-immunophenotype-of-mast-cells-and-its-utility-in-the-diagnostic-work-up-of-systemic-mastocytosis
#16
REVIEW
Cristina Teodosio, Andrea Mayado, Laura Sánchez-Muñoz, José M Morgado, María Jara-Acevedo, Ivan Álvarez-Twose, Andrés C García-Montero, Almudena Matito, Caldas Caldas, Luis Escribano, Alberto Orfao
SM comprises a heterogeneous group of disorders, characterized by an abnormal accumulation of clonal MCs in 1 or more tissues, frequently involving the skin and BM. Despite the fact that most adult patients (>90%) carry the same genetic lesion (D816V KIT mutation), the disease presents with multiple variants with very distinct clinical and biologic features, a diverse prognosis, and different therapeutic requirements. Recent advances in the standardization of the study of BM MC by MFC allowed reproducible identification and characterization of normal/reactive MCs and their precursors, as well as the establishment of the normal MC maturational profiles...
January 2015: Journal of Leukocyte Biology
https://www.readbyqxmd.com/read/26714888/facial-erythema-of-rosacea-aetiology-different-pathophysiologies-and-treatment-options
#17
REVIEW
Martin Steinhoff, Martin Schmelz, Jürgen Schauber
Rosacea is a common chronic skin condition that displays a broad diversity of clinical manifestations. Although the pathophysiological mechanisms of the four subtypes are not completely elucidated, the key elements often present are augmented immune responses of the innate and adaptive immune system, and neurovascular dysregulation. The most common primary feature of all cutaneous subtypes of rosacea is transient or persistent facial erythema. Perilesional erythema of papules or pustules is based on the sustained vasodilation and plasma extravasation induced by the inflammatory infiltrates...
June 15, 2016: Acta Dermato-venereologica
https://www.readbyqxmd.com/read/26307938/genetic-vs-environmental-factors-that-correlate-with-rosacea-a-cohort-based-survey-of-twins
#18
Nely Aldrich, Meg Gerstenblith, Pingfu Fu, Marie S Tuttle, Priya Varma, Erica Gotow, Kevin D Cooper, Margaret Mann, Daniel L Popkin
IMPORTANCE: To our knowledge, this is the first study on rosacea to formally define genetic and environmental contributions. OBJECTIVES: To study a cohort of identical and fraternal twins to determine whether genetic factors contribute to rosacea development and, if genetic factors are present, quantitatively estimate the genetic contribution, as well as to identify environmental factors that correlate with rosacea by controlling for genetic susceptibility. DESIGN, SETTING, AND PARTICIPANTS: Identical and fraternal twins were surveyed regarding risk factors implicated in rosacea...
November 2015: JAMA Dermatology
https://www.readbyqxmd.com/read/26256428/rosacea-is-associated-with-chronic-systemic-diseases-in-a-skin-severity-dependent-manner-results-of-a-case-control-study
#19
COMPARATIVE STUDY
Barbara M Rainer, Alexander H Fischer, Dimitre Luz Felipe da Silva, Sewon Kang, Anna L Chien
BACKGROUND: Rosacea is a common chronic inflammatory dermatosis of unclear origin. It has been associated with systemic comorbidities, but methodical studies addressing this association are lacking. OBJECTIVE: We evaluated: (1) the association between rosacea and systemic comorbidities; and (2) if the severity of rosacea is impacted by comorbidities. METHODS: This was a case-control study: patients with rosacea were matched (1:1) to rosacea-free control subjects by age, sex, and race...
October 2015: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/26103573/personal-history-of-rosacea-and-risk-of-incident-cancer-among-women-in-the-us
#20
W-Q Li, M Zhang, F W Danby, J Han, A A Qureshi
BACKGROUND: Rosacea is an inflammatory skin disease. We examined the association between personal history of rosacea and risk of incident cancers. METHODS: A total of 75 088 whites were included from the Nurses' Health Study II (1991-2011). Information on clinician-diagnosed rosacea and diagnosis year was collected in 2005. All cancers other than basal cell carcinoma (BCC) were confirmed. RESULTS: During 1 447 205 person-years, we identified 5194 cases with internal malignancies and 5788 with skin cancers...
July 28, 2015: British Journal of Cancer
label_collection
label_collection
6283
1
2
2016-01-26 18:45:08
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"